Metabolic biomarker modeling for predicting clinical diagnoses through microfluidic paper-based analytical devices.

• Metabolic biomarker profiles were used for the prediction of clinical diagnoses. • k-NN classifiers were fitted to demonstrate the reliability of µPADs derived data. • Predictors were associated with glucose, lactate, and uric acid concentrations. • Metabolic disorders were suitably predicted with 95.0% overall accuracy. • The modeling addressed here proved that the µPADs could be applied in telemedicine. The development of microfluidic devices for point-of-care (POC) testing has been widely applied for food quality control, environmental monitoring, and clinical diagnoses. Regarding the latter, microfluidic paper-based analytical devices (µPADs) have a great potential in developing portable and disposable platforms for fast disease-relevant biomarker detection in remote areas. In this work, k-nearest neighbors (k-NN) classifiers were applied to demonstrate the reliability of using chemical data obtained from µPADs for diagnosis of diseases like diabetes mellitus and hyperuricemia. Predictors based on glucose, lactate, and uric acid biomarkers were evaluated to reach this goal. Healthy adults were differentiated from the diagnosed patients with a perfect success rate. Metabolic disorders were suitably predicted with 95.0% overall accuracy. This model also showed sensitivities and specificities in the ranges 75–100% and 93–100%, respectively, indicating that the classification protocol is robust. The k-NN modeling proved the potential of the µPADs to be applied in telemedicine for reliable off-site diagnoses. [ABSTRACT FROM AUTHOR]